findmyKOL
Clinical trialNCT02600715CompletedPhase 4Interventional

Reduction of Bladder Injection Pain With Belladonna Opiate Suppository

SponsorEdgar LeClaire, MDEnrollment26Overactive BladderPainful Bladder SyndromeUrinary Bladder, NeurogenicUrinary Urge Incontinence
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test whether using belladonna \& opiate suppositories (B\&Os) can improve patient discomfort during Onabotulinumtoxin A (BoNT) injection into the bladder for treatment of overactive bladder, neurogenic detrusor overactivity, or interstitial cystitis.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Kansas School of Medicine - Wichita

    Wichita, Kansas, United States

  • Wichita Women'S Pelvic Surgery Center at Associates in Women'S Health

    Wichita, Kansas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Active B&O suppository of belladonnaMorphine →Botulinum toxin type A →PlaceboBelladonna extract, USP
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2015
Primary completion
26 Jun 2017
Completion
26 Jun 2017
Last update posted
20 Sept 2018
Registered enrollment
26
Registry id
NCT02600715

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.